# Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

> **NCT01076621** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 176 (actual)

## Conditions studied

- Menopause
- Postmenopausal Bleeding

## Interventions

- **DRUG:** 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)

## Key facts

- **NCT ID:** NCT01076621
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2014-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076621, "Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01076621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*